Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 3/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL487322 | 0.94 | ATM (0.41) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL4895739 | 0.92 | ALDH1A1 (0.39) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL3786038 | 0.91 | TSHR (0.50) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL3791086 | 0.91 | TSHR (0.50) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL4889687 | 0.86 | TSHR (0.47) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL4888226 | 0.86 | HCAR2 (0.47) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL4888287 | 0.86 | HCAR2 (0.47) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL5182457 | 0.85 | TSHR (0.52) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL10713340 | 0.85 | TSHR (0.52) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL5180107 | 0.85 | TSHR (0.52) | TSHRALDH1A1TP53HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4011993-A1 | ADHESIVE COMPOSITION WHICH EASILY DISINTEGRATES IN WATER | Toagosei Co., Ltd. (JP) | 2022-06-15 | — | — | EP | disclosed |
| EP-3126321-B1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | AFINITICA TECH S L (ES) | 2018-03-07 | — | — | EP | disclosed |
| US-9670145-B2 | Process for preparing 1,1-disubstituted ethylene monomers | AFINITICA TECHNOLOGIES, S. L. (ES) | 2017-06-06 | — | — | US | disclosed |
| US-20170022151-A1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | AFINITICA TECHNOLOGIES, S. L. (ES) | 2017-01-26 | — | — | US | disclosed |
| EP-2927209-A1 | Process for preparing 1,1-disubstituted ethylenic monomers | Afinitica Technologies, S. L. (ES) | 2015-10-07 | — | — | EP | disclosed |
| US-20080293872-A1 | ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER | HENKEL AG & CO. KGAA (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080287574-A1 | ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER | HENKEL AG & CO. KGAA (DE) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022151-A1 | PROCESS FOR PREPARING 1,1-DISUBSTITUTED ETHYLENE MONOMERS | ESD, AP1M1, SULT1A1 | TSHR 4823/4885ALDH1A1 62/4885TP53 4706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.